MediWound Ltd. logo
MediWound Ltd. MDWD
$ 13.59 0.37%

MediWound Ltd. Revenue | MDWD

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue MediWound Ltd.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
21.8 M 31.8 M 3.4 M 2.5 M 1.56 M 601 K 259 K - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
31.8 M 259 K 8.84 M

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Biotechnology industry

Issuer Revenue Price % 24h Market Cap Country
Vericel Corporation Vericel Corporation
VCEL
276 M $ 57.41 -1.46 % $ 2.89 B usaUSA
Vir Biotechnology Vir Biotechnology
VIR
68.6 M $ 8.37 -5.64 % $ 1.16 B usaUSA
Veracyte Veracyte
VCYT
517 M $ 25.08 0.16 % $ 1.97 B usaUSA
Viking Therapeutics Viking Therapeutics
VKTX
10.7 K $ 24.72 -4.35 % $ 2.79 B usaUSA
Vanda Pharmaceuticals Vanda Pharmaceuticals
VNDA
216 M $ 3.44 -6.27 % $ 203 M usaUSA
VistaGen Therapeutics VistaGen Therapeutics
VTGN
1.27 M $ 0.16 -12.33 % $ 6.09 M usaUSA
Voyager Therapeutics Voyager Therapeutics
VYGR
40.4 M $ 1.52 -5.9 % $ 89.2 M usaUSA
Verrica Pharmaceuticals Verrica Pharmaceuticals
VRCA
35.6 M $ 2.74 -5.03 % $ 29.2 M usaUSA
Wave Life Sciences Ltd. Wave Life Sciences Ltd.
WVE
42.7 M $ 2.56 -6.07 % $ 432 M singaporeSingapore
XBiotech XBiotech
XBIT
4.01 M $ 1.75 4.17 % $ 53.4 M usaUSA
XTL Biopharmaceuticals Ltd. XTL Biopharmaceuticals Ltd.
XTLB
451 K $ 1.37 -7.43 % $ 922 M israelIsrael
ADMA Biologics ADMA Biologics
ADMA
510 M $ 13.18 -1.2 % $ 3.14 B usaUSA
Exicure Exicure
XCUR
500 K $ 0.96 -7.24 % $ 6.05 M usaUSA
Xencor Xencor
XNCR
126 M $ 33.48 -1.56 % $ 2.49 B usaUSA
Burford Capital Limited Burford Capital Limited
BUR
413 M $ 3.24 -5.55 % $ 710 M britainBritain
Daré Bioscience Daré Bioscience
DARE
1.03 M $ 0.41 -9.93 % $ 4.58 M usaUSA
Fate Therapeutics Fate Therapeutics
FATE
6.65 M $ 0.92 -9.07 % $ 109 M usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
1.4 B $ 91.28 -1.89 % $ 10.9 B usaUSA
Hutchison China MediTech Limited Hutchison China MediTech Limited
HCM
549 M $ 13.18 -2.04 % $ 11.3 B chinaChina
Aptorum Group Limited Aptorum Group Limited
APM
431 K - - $ 5.72 M chinaChina
iBio iBio
IBIO
100 K $ 0.83 3.01 % $ 86.4 M usaUSA
Karyopharm Therapeutics Karyopharm Therapeutics
KPTI
146 M $ 0.02 -56.5 % $ 219 usaUSA
FSD Pharma FSD Pharma
HUGE
257 K - 5743.5 % $ 69.7 M canadaCanada
BioAtla BioAtla
BCAB
300 K $ 1.74 0.64 % $ 102 M usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
589 M - - $ 3.85 B usaUSA
UroGen Pharma Ltd. UroGen Pharma Ltd.
URGN
110 M $ 28.91 -8.89 % $ 1.39 B israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
117 M $ 13.01 0.74 % $ 1.16 B usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
3.2 K - - $ 374 usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
7.5 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
130 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
886 K - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
123 M - 1.93 % $ 17.4 M usaUSA
AlloVir AlloVir
ALVR
165 K - 4.14 % $ 49.1 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
1 B - - $ 5.18 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
58.7 B - - $ 96.9 B britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
5.34 B - 0.49 % $ 251 B cayman-islandsCayman-islands
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
31.4 M $ 0.23 -12.11 % $ 16.8 K usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
37 K - - $ 100 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
7.14 M - -3.03 % $ 260 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
129 M - -0.88 % $ 598 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
170 K - -16.75 % $ 25.8 M usaUSA